SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharmaceuticals gets nod to buy back shares worth Rs 12 crore

11 Sep 2017 Evaluate

Jenburkt Pharmaceuticals has received an approval for Buyback of its fully paid-up equity shares of face value of Rs 10 each from its equity shareholders, as on record date to be announced in due course of time, for an amount not exceeding Rs 12 crore, at a price of Rs 576 per equity share which is 22.37% of the fully paid-up equity share capital and free reserves as per the latest audited balance sheet of the company for the financial year ended on March 31, 2017. The Board of Directors of the company at their meeting held on September 09, 2017 has approved for the same.

The Buyback offer will comprise a purchase of up to 2,08,333 equity shares, representing 4.48% of the paid up equity capital of the company. The Buyback offer will be on a proportionate basis through the Tender Offer route as prescribed under the Buyback Regulations, from all of the equity shareholders/ beneficial owners who hold Equity Shares on the record date for the proposed Buyback, which will be determined in due course.

Jenburkt Pharmaceuticals is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.


Jenburkt Pharma Share Price

1025.60 6.35 (0.62%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×